Le Lézard
Classified in: Science and technology, Business, Covid-19 virus
Subjects: TNM, PDT

VEON acquires strategic stake in Bangladesh's leading full-stack B2B commerce platform, ShopUp

AMSTERDAM, Oct. 20, 2020 /PRNewswire/ -- VEON Ltd. (NASDAQ: VEON) and (Euronext Amsterdam: VEON), through VEON Ventures, has joined Sequoia Capital India and Flourish Ventures as investors in ShopUp, Bangladesh's leading full-stack B2B commerce platform for small businesses, becoming ShopUp's first strategic corporate investor.

The investment enables VEON Ventures to support ShopUp's fast-growing digital ecosystem for micro, small and medium-sized enterprises (MSMEs), which form a vital backbone of Bangladesh's economy, as well as providing significant opportunities for developing mobile financial services for ShopUp's users.

As Bangladesh's leading full-stack B2B commerce company, ShopUp provides B2B sourcing, logistics and financial services to MSMEs through its mobile-first digital platform and market-leading last mile logistics service, RedX. ShopUp is already used by a large portion of Bangladeshi local businesses, helping neighbourhood shops and online sellers overcome the supply chain challenges of Bangladesh's highly fragmented wholesale, retail and distribution channels.

ShopUp's embedded financial services product provides MSMEs with access to digital credit through partnerships with leading local financial institutions, broadening financial inclusion to communities of small businesses that often lack access to basic banking services.

Sergi Herrero, VEON's co-CEO, said: "Our investment in ShopUp offers VEON Ventures a fantastic opportunity to back one of the leading digital players in a strategic market for VEON and one of the world's fastest growing economies. By combining VEON's expertise in digital financial services with ShopUp's unique sourcing and logistics capabilities, we look forward to serving the business needs of Bangladesh's vibrant MSME community while helping to promote financial inclusion throughout the nation's millions of small business owners."

Afeef Zaman, co-Founder and CEO of ShopUp, said: "We knew we would witness massive adoption of the internet and technology by Bangladesh's small businesses and founded ShopUp because we wanted to play our part in redefining the nation's growth story through this transformation. COVID-19 makes this shift even more critical for Bangladesh's smaller businesses as supply chain pressures intensify. An investment from a leading international digital player such as VEON is an important step in our ongoing support of the MSME community, allowing us to increase our reach with retailers, suppliers and manufacturers."

VEON's investment was led by the VEON Ventures division, which pursues investment opportunities across digital assets and businesses with the ability to scale VEON's capabilities in mobile financial services, adtech and next-generation media content in order to enrich the experience of VEON's 205 million customers worldwide.

VEON's investment in ShopUp was made alongside Flourish Ventures and Sequoia Capital India. Both investment firms co-led the current investment round for ShopUp, with additional participation from Speedinvest and Lonsdale in what is the largest Series A round of its kind for a Bangladeshi start-up.

About VEON and ShopUp

VEON is a NASDAQ and Euronext Amsterdam-listed global provider of connectivity and internet services. For more information visit: www.veon.com.

ShopUp is Bangladesh's leading full-stack B2B Commerce platform for small businesses (neighbourhood shops and online sellers). We provide easy access to B2B sourcing, last-mile logistics, digital credit and business management solutions. To know more about our work, visit www.shopup.com.bd.


This release contains "forward-looking statements", as the phrase is defined in Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Forward-looking statements are not historical facts, and include statements relating to, among other things, the potential benefits of the transaction described above. Forward-looking statements are inherently subject to risks and uncertainties, many of which VEON cannot predict with accuracy and some of which VEON might not even anticipate. The forward-looking statements contained in this release speak only as of the date of this release. VEON does not undertake to publicly update, except as required by U.S. federal securities laws, any forward-looking statement to reflect events or circumstances after such dates or to reflect the occurrence of unanticipated events.

VEON Contacts:
Kieran Toohey
Tel: +31 20 79 77 200 

Investor Relations
Nik Kershaw
Tel: +31 20 79 77 200


These press releases may also interest you

at 13:21
This week, presenter, bestselling author and strategist Ismael Cala launched the daily digital newspaper www.CalaBienestar.news, a website containing news about health, wellbeing and lifestyle. "This is the result ?still a work in progress? of an...

at 13:15
Johnson Controls, a global leader for smart and sustainable buildings, and the architect of OpenBlue connected solutions, today announced that Sensormatic Solutions, its leading global retail solutions portfolio, released preliminary shopper visit...

at 12:35
In lieu of an in-person update to the media, Dr. Theresa Tam, Canada's Chief Public Health Officer, issued the following statement today: "As the resurgence of COVID-19 activity continues in Canada, we are tracking a range of epidemiological...

at 12:10
The Ventilation Equipment Market is poised to experience spend growth of more than USD 8 billion between 2020-2024 at a CAGR of over 5.15%. The report also provides the market impact and new opportunities created due to the COVID-19 pandemic. Request...

at 11:35
Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as "Dr. Reddy's") today announced that it has entered into a definitive agreement with Glenmark Pharmaceuticals Ltd. to acquire,...

at 11:13
Drug shortages remain a global challenge and COVID-19 has increased demand for certain drugs, adding to the complexity of ensuring drug supply where it is needed. The Government of Canada remains steadfast in its efforts to ensure Canadians have...

News published on 20 october 2020 at 04:46 and distributed by: